Search

everythinglearnresearchcommunity

for

Search:↓

Certain skin diseases are linked to Agent Orange and similar chemicals; veterans should be screened and informed about uncertain risks, and current data doesn't link spironolactone with breast cancer.

Some skin, hair, and nail supplements can be toxic, interact with medications, affect lab tests, and may increase cancer risk.

Hair follicles have a more inactive cell cycle than other skin cells, which may help develop targeted therapies for skin diseases and cancer.

Nutrition plays a key role in managing skin disorders, with specific dietary changes helping improve conditions like acne, dermatitis, psoriasis, alopecia, and skin cancer.

Olive oil byproducts can improve skin and hair care products and help prevent skin cancer.

Hair follicles are vital for skin health, cancer prevention, and wound healing.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Dermoscopy can help assess the severity of chronic radiation-induced skin damage in head and neck cancer patients.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

Blocking COX, especially COX-2, in the skin can reduce inflammation and pain and may help prevent skin cancer.

Cox-2 significantly contributes to the development and progression of skin and esophageal cancers.

Keratin 17 is linked to various diseases, including cancer and skin conditions, and may be a target for diagnosis and treatment.

Air pollution harms skin, causing aging, diseases, and cancer.

Beta-catenin is crucial for skin cell growth, development, and cancer formation.

Minocycline reduces acne rash, pyridoxine lowers hand-foot syndrome risk, and scalp cooling lessens hair loss from cancer treatments.

Hedgehog signaling can create new hair follicles in adult skin but may increase cancer risk.

Older people often have untreated genital skin diseases due to embarrassment and lack of medical attention, which can lead to discomfort and even cancer risk.

Older adults commonly experience wrinkles, itchy skin, psoriasis, fungal infections, skin growths, grey hair, hair loss, and nail ridging, but no skin cancer was found in this group.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

New cancer drugs often cause skin and nail problems.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

CD34 is crucial for skin tumor development in mice.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Disrupting Stat3 in hair follicle stem cells greatly reduces skin tumor formation.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.